"Drug trial offers new hope in preventing Alzheimer's"
Source: Sydney Morning Herald
Published: 17 May 2012
Category: Pharmaceutical
Rating:
(5 stars)
Keywords: alzheimer's drug crenezumab colombia
what they said (Hover the mouse cursor over underlined words for more info)
In a clinical trial that could lead to treatments that prevent Alzheimer's disease, people who are genetically guaranteed to suffer from the disease years from now - but who do not yet have any symptoms - will for the first time be given a drug intended to stop them from developing it, US health officials have announced.
The original article can be found at: http://www.smh.com.au/national/health/drug-trial-offers-new-hope-in-preventing-alzheimers-20120516-1yr85.html
| Criteria |
Rating |
| Novelty of Treatment |
Satisfactory (?) |
| Availability of Treatment |
Satisfactory (?) |
| Treatment Options |
Satisfactory (?) |
| Disease Mongering |
Satisfactory (?) |
| Evidence |
Not Applicable |
| Quantification of Benefits of Treatment |
Not Applicable |
| Harms of Treatment |
Satisfactory (?) |
| Costs of Treatment |
Satisfactory (?) |
| Sources of Information |
Satisfactory (?) |
| Relies on Press Release |
Not Applicable |
what we said (Hover the mouse cursor over underlined words for more info)
This forthcoming, very expensive, trial of a monoclonal antibody - which was licensed in 2006 - to prevent Alzheimer's Disease, has created enormous and deserved media interest. This story, which seems to have come directly from The New York Times (http://www.nytimes.com/2012/05/16/health/research/prevention-is-goal-of-alzheime rs-drug-trial.html?pagewanted=all), is highly informative and well researched and rates well.
public forum
There are currently no comments on this article.
|